Target- |
MechanismImmunomodulators |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date18 Nov 2005 |
100 Clinical Results associated with Famar Health Care Services Madrid SA
0 Patents (Medical) associated with Famar Health Care Services Madrid SA
100 Deals associated with Famar Health Care Services Madrid SA
100 Translational Medicine associated with Famar Health Care Services Madrid SA